Compare · BBNX vs MDLN
BBNX vs MDLN
Side-by-side comparison of Beta Bionics Inc. (BBNX) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BBNX and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $47.24B, about 53.2x BBNX ($888.1M).
- Over the past year, BBNX is down 18.3% and MDLN is down 10.5% - MDLN leads by 7.8 points.
- BBNX has been more active in the news (10 items in the past 4 weeks vs 7 for MDLN).
- MDLN has more recent analyst coverage (25 ratings vs 21 for BBNX).
PerformanceBBNX-42.15%MDLN-10.53%
2025-12-17+0.00%2026-10-16
- Company
- Beta Bionics Inc.
- Medline Inc.
- Price
- $16.89-2.62%
- $36.46-0.36%
- Market cap
- $888.1M
- $47.24B
- 1M return
- -21.32%
- +13.55%
- 1Y return
- -18.31%
- -10.53%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2025
- News (4w)
- 10
- 7
- Recent ratings
- 21
- 25
Latest BBNX
- BBNX DEADLINE: Levi & Korsinsky Reminds Beta Bionics, Inc. Investors of Upcoming Securities Class Action Deadline
- Jefferies initiated coverage on Beta Bionics with a new price target
- BBNX Investor Alert: Beta Bionics, Inc. Securities Class Action Notice - Contact Levi & Korsinsky
- SEC Form SCHEDULE 13G filed by Beta Bionics Inc.
- Barclays initiated coverage on Beta Bionics with a new price target
- SEC Form 4 filed by Beta Bionics Inc.
- Beta Bionics to Announce Third Quarter 2026 Financial Results on October 27, 2026
- Director Jones Christy sold $147,890 worth of shares (6,430 units at $23.00) as part of a pre-agreed trading plan, decreasing direct ownership by 25% to 19,564 units (SEC Form 4)
- Wells Fargo initiated coverage on Beta Bionics with a new price target
- Beta Bionics Announces Agreement Integrate the iLet® Bionic Pancreas and mint™ with Senseonics’ Eversense® 365
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M